Location: New York, NY
CIK: 0001974915 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 14, 2024
Total Value: $1.209B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CYTK | Cytokinetics Inc | 2,150,000 | $151M | 12.5% | $76.39 | +1.3% | COM NEW | 23282W605 |
| JAZZ | Jazz Pharmaceuticals PLC | 1,100,000 | $132M | 11.0% | $124.01 | -1.2% | SHS USD | G50871105 |
| NBIX | Neurocrine Biosciences Inc | 710,000 | $97.92M | 8.1% | $115.11 | +18.6% | COM | 64125C109 |
| ASND | Ascendis Pharma A/S | 525,000 | $79.36M | 6.6% | $125.95 | — | SPONSORED ADR | 04351P101 |
| GMED | Globus Medical Inc | 1,000,000 | $53.64M | 4.4% | $49.74 | +8.1% | CL A | 379577208 |
| SLNO | Soleno Therapeutics Inc | 1,250,000 | $53.5M | 4.4% | $28.45 | +59.0% | COM | 834203309 |
| ALNY | Alnylam Pharmaceuticals Inc | 350,000 | $52.31M | 4.3% | $167.17 | -0.2% | COM | 02043Q107 |
| ONC | BeiGene Ltd | 325,000 | $50.83M | 4.2% | $156.39 | — | SPONSORED ADR | 07725L102 |
| — | Inari Medical Inc | 800,000 | $38.38M | 3.2% | $47.98 | — | COM | 45332Y109 |
| — | Applied Therapeutics Inc | 5,110,000 | $34.75M | 2.9% | $3.99 | — | COM | 03828A101 |
| LQDA | Liquidia Corp | 2,000,000 | $29.5M | 2.4% | $10.47 | +32.8% | COM NEW | 53635D202 |
| ALXO | ALX Oncology Holdings Inc | 2,610,000 | $29.1M | 2.4% | $11.15 | +25.9% | COM | 00166B105 |
| AZN | AstraZeneca PLC | 400,000 | $27.1M | 2.2% | $67.50 | — | SPONSORED ADR | 046353108 |
| QURE | uniQure NV | 4,725,000 | $24.57M | 2.0% | $6.46 | -11.2% | SHS | N90064101 |
| INSM | Insmed Inc | 750,000 | $20.35M | 1.7% | $25.93 | +7.9% | COM PAR $.01 | 457669307 |
| ARGX | Argenx SE | 50,000 | $19.69M | 1.6% | $393.72 | — | SPONSORED ADR | 04016X101 |
| XENE | Xenon Pharmaceuticals Inc | 400,000 | $17.22M | 1.4% | $41.33 | +11.3% | COM | 98420N105 |
| TGTX | TG Therapeutics Inc | 1,050,000 | $15.97M | 1.3% | $15.93 | 0.0% | COM | 88322Q108 |
| — | Astria Therapeutics Inc | 1,100,000 | $15.48M | 1.3% | $14.07 | — | COM | 04635X102 |
| BMRN | BioMarin Pharmaceutical Inc | 175,000 | $15.28M | 1.3% | $89.52 | 0.0% | COM | 09061G101 |
| — | Alpine Immune Sciences Inc | 350,000 | $13.87M | 1.1% | $39.64 | — | COM | 02083G100 |
| SLDB | Solid Biosciences Inc | 1,035,000 | $13.79M | 1.1% | $9.15 | +2.2% | COM NEW | 83422E204 |
| DNTH | Dianthus Therapeutics Inc | 455,000 | $13.65M | 1.1% | $18.56 | +17.1% | COM | 252828108 |
| APLS | Apellis Pharmaceuticals Inc | 225,000 | $13.23M | 1.1% | $63.75 | 0.0% | COM | 03753U106 |
| SRPT | Sarepta Therapeutics Inc | 100,000 | $12.95M | 1.1% | $122.50 | 0.0% | COM | 803607100 |
| PRAX | Praxis Precision Medicines Inc | 210,000 | $12.81M | 1.1% | $44.86 | 0.0% | COM NEW | 74006W207 |
| IMTX | Immatics NV | 1,200,000 | $12.61M | 1.0% | $9.21 | +26.7% | SHS | N44445109 |
| INCY | Incyte Corp | 200,000 | $11.39M | 0.9% | $60.02 | 0.0% | COM | 45337C102 |
| MGNX | MacroGenics Inc | 725,000 | $10.67M | 0.9% | $15.11 | 0.0% | COM | 556099109 |
| AGIO | Agios Pharmaceuticals Inc | 325,000 | $9.503M | 0.8% | $26.78 | 0.0% | COM | 00847X104 |
| — | Shockwave Medical Inc | 25,000 | $8.141M | 0.7% | $325.63 | — | COM | 82489T104 |
| KRYS | Krystal Biotech Inc | 45,000 | $8.007M | 0.7% | $138.91 | 0.0% | COM | 501147102 |
| KALV | KalVista Pharmaceuticals Inc | 655,000 | $7.768M | 0.6% | $13.33 | 0.0% | COM | 483497103 |
| GERN | Geron Corp | 2,200,000 | $7.26M | 0.6% | $2.23 | 0.0% | COM | 374163103 |
| ACLX | Arcellx Inc | 100,000 | $6.955M | 0.6% | $52.43 | +20.9% | COMMON STOCK | 03940C100 |
| EXAS | Exact Sciences Corp | 100,000 | $6.906M | 0.6% | $63.25 | 0.0% | COM | 30063P105 |
| FULC | Fulcrum Therapeutics Inc | 695,000 | $6.561M | 0.5% | $4.44 | +101.2% | COM | 359616109 |
| VKTX | Viking Therapeutics Inc | 75,000 | $6.15M | 0.5% | $44.50 | 0.0% | COM | 92686J106 |
| — | Passage Bio Inc | 4,500,000 | $6.075M | 0.5% | $1.35 | — | COM | 702712100 |
| ALLO | Allogene Therapeutics Inc | 1,350,000 | $6.035M | 0.5% | $4.17 | 0.0% | COM | 019770106 |
| FATE | Fate Therapeutics Inc | 800,000 | $5.872M | 0.5% | $2.36 | +162.2% | COM | 31189P102 |
| VYGR | Voyager Therapeutics Inc | 600,000 | $5.586M | 0.5% | $9.31 | — | COM | 92915B106 |
| RLMD | Relmada Therapeutics Inc | 1,200,000 | $5.58M | 0.5% | $4.64 | +3.8% | COM | 75955J402 |
| BIO | Bio-Rad Laboratories Inc | 15,000 | $5.188M | 0.4% | $328.84 | 0.0% | CL A | 090572207 |
| RARE | Ultragenyx Pharmaceutical Inc | 110,000 | $5.136M | 0.4% | $47.17 | 0.0% | COM | 90400D108 |
| — | Lyra Therapeutics Inc | 800,000 | $4.976M | 0.4% | $5.24 | — | COM | 55234L105 |
| GLPG | Galapagos NV | 130,000 | $4.186M | 0.3% | $40.65 | — | SPON ADR | 36315X101 |
| ANRO | Alto Neuroscience Inc | 250,000 | $3.837M | 0.3% | $15.65 | 0.0% | COM SHS | 02157Q109 |
| LXEO | Lexeo Therapeutics Inc | 175,000 | $2.744M | 0.2% | $15.64 | 0.0% | COM | 52886X107 |
| PRME | Prime Medicine Inc | 360,000 | $2.52M | 0.2% | $7.59 | -0.1% | COM | 74168J101 |
| NVAX | Novavax Inc | 500,000 | $2.39M | 0.2% | $4.64 | 0.0% | COM NEW | 670002401 |
| PCRX | Pacira BioSciences Inc | 80,000 | $2.338M | 0.2% | $29.26 | +5.0% | COM | 695127100 |
| — | Atara Biotherapeutics Inc | 2,800,000 | $1.943M | 0.2% | $0.69 | — | COM | 046513107 |
| — | Achilles Therapeutics PLC | 1,500,000 | $1.875M | 0.2% | $1.22 | — | SPONSORED ADS | 00449L102 |
| — | Chimerix Inc | 1,400,000 | $1.484M | 0.1% | $0.96 | — | COM | 16934W106 |
| — | Reneo Pharmaceuticals Inc | 295,375 | $490K | 0.0% | $1.60 | — | COM | 75974E103 |
| AFMDQ | Affimed NV | 55,000 | $292K | 0.0% | $5.69 | 0.0% | ORDINARY SHS NEW | N01045207 |
| — | Lyell Immunopharma Inc | 130,000 | $290K | 0.0% | $2.23 | — | COM | 55083R104 |